During Abu Dhabi Global Health Week (ADGHW), the Department of Health – Abu Dhabi (DoH), the regulator of the heal...
US-based ATED Therapeutics has announced a new diagnostic test for Parkinson’s Disease, developed at Hebrew Univer...
In a major step toward democratising access to advanced healthcare, Burjeel Holdings, a leading super-specialty healthca...
Globalpharma, the UAE’s leading pharmaceutical manufacturer and a wholly owned subsidiary of Dubai Investments PJS...
Burjeel Medical City (BMC), the flagship facility of Burjeel Holdings, has launched a state-of-the-art Epilepsy Monitori...
The Ministry of Health in Egypt has signed a Memorandum of Understanding (MoU) with Siemens Healthineers on to launch th...
South Korea-based Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and...
The Saudi National Unified Procurement Company (NUPCO) has officially announced the bidding results for the three-year c...
Italy-based Tethis S.p.A., a pioneer in standardised liquid biopsy platform development, and Sheba Medical Center, ...
US-based biotech firm Indaptus Therapeutics, Inc. has secured new patent approvals in China, Japan and Israel for its De...
South Korea-based startup Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnos...
India-based Leucine Rich Bio, South Asia’s pioneering microbiome company, has announced a strategic collaboration ...
Israel-based CollPlant Biotechnologies, a regenerative and aesthetics medicine company developing innovative technologie...
Indonesian Health Minister Budi Gunadi Sadikin and Saudi Arabian Health Minister Fahd Abdulrahman Al-Jalajel have formal...
India-based Augnito, a global leader in medical voice artificial intelligence (AI) technology, and Almoosa Health, a pre...
Saudi German Health (SGH) has signed a Memorandum of Understanding (MoU) with Becton, Dickinson and Company (BD), a...
Emirates Health Services (EHS) and Dell Technologies have signed a Memorandum of Understanding (MoU) to drive advancemen...
Teva Pharmaceuticals' Q4 2024 results reflect both the challenges and successes of the company as it continues its "Pivo...
